var data={"title":"Topical tretinoin (topical all-trans retinoic acid): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Topical tretinoin (topical all-trans retinoic acid): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7092?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=topical-tretinoin-topical-all-trans-retinoic-acid-patient-drug-information\" class=\"drug drug_patient\">see &quot;Topical tretinoin (topical all-trans retinoic acid): Patient drug information&quot;</a> and <a href=\"topic.htm?path=topical-tretinoin-topical-all-trans-retinoic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Topical tretinoin (topical all-trans retinoic acid): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230490\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Atralin;</li>\n      <li>Avita;</li>\n      <li>Refissa;</li>\n      <li>Renova;</li>\n      <li>Renova Pump;</li>\n      <li>Retin-A;</li>\n      <li>Retin-A Micro;</li>\n      <li>Retin-A Micro Pump;</li>\n      <li>Tretin-X</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230491\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Retin-A;</li>\n      <li>Retin-A Micro;</li>\n      <li>Stieva-A;</li>\n      <li>Vitamin A Acid</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230507\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Acne Products;</li>\n      <li>\n        Retinoic Acid Derivative;</li>\n      <li>\n        Topical Skin Product, Acne</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230493\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acne vulgaris:</b> Topical: Apply once daily to acne lesions before bedtime or in the evening.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Palliation of fine wrinkles (Refissa/Renova), mottled hyperpigmentation, and tactile roughness of facial skin (Refissa):</b> Topical: Apply a pea-sized amount of cream to entire face once daily in the evening or before bedtime.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230501\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=topical-tretinoin-topical-all-trans-retinoic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Topical tretinoin (topical all-trans retinoic acid): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">\n      <b>Acne vulgaris:</b> Children &ge;10 years (Atralin) or &ge;12 years (Retin-A Micro, Tretin-X) and Adolescents: Topical: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230494\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing; safety/efficacy of Refissa has not been established in patients &gt;50 years of age; safety/efficacy of Renova has not been established in patients &gt;71 years of age.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24037518\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24037519\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230472\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Avita: 0.025% (20 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Refissa: 0.05% (20 g, 40 g) [contains edetate disodium, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Renova: 0.02% (40 g, 60 g) [contains benzyl alcohol, cetyl alcohol, edetate disodium, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Renova Pump: 0.02% (44 g) [contains benzyl alcohol, cetyl alcohol, edetate disodium, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A: 0.025% (20 g, 45 g); 0.05% (20 g, 45 g); 0.1% (20 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tretin-X: 0.0375% (35 g [DSC]); 0.075% (35 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.025% (20 g, 45 g); 0.05% (20 g, 40 g, 45 g, 60 g [DSC]); 0.1% (20 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Atralin: 0.05% (45 g) [contains benzyl alcohol, butylparaben, ethylparaben, fish collagen hydrolyzates, isobutylparaben, methylparaben, propylparaben, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Avita: 0.025% (20 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A: 0.01% (15 g, 45 g); 0.025% (15 g, 45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A Micro: 0.04% (20 g, 45 g); 0.1% (20 g, 45 g) [contains benzyl alcohol, disodium edta, propylene glycol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A Micro Pump: 0.04% (50 g) [contains benzyl alcohol, disodium edta, propylene glycol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A Micro Pump: 0.06% (50 g) [contains benzyl alcohol, edetate disodium, propylene glycol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Retin-A Micro Pump: 0.08% (50 g); 0.1% (50 g) [contains benzyl alcohol, disodium edta, propylene glycol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.01% (15 g, 45 g); 0.025% (15 g, 45 g); 0.04% (20 g, 45 g, 50 g); 0.05% (45 g); 0.1% (20 g, 45 g, 50 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tretin-X: 0.025% [DSC], 0.1% [DSC], 0.05% [DSC] [contains benzyl alcohol, cetearyl alcohol, disodium edta, fd&amp;c red #40, methylparaben, propylparaben, tartrazine (fd&amp;c yellow #5), trolamine (triethanolamine)]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230458\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45759681\" class=\"block foccan drugH1Div\"><span class=\"drugH1\">Dosage Forms: Canada</span>\n    <p style=\"text-indent:0em;display:inline\">Information with regard to form, strength, and availability of products uniquely available in Canada but currently not available in the US. Refer also to Dosage forms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream, External:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Retin-A: 0.01% (30 g); 0.025% (30 g); 0.05% (30 g); 0.1% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Stieva-A: 0.01%, 0.025%, 0.05%, (25 g, 45 g); 0.1% (45 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gel, External:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Retin-A: 0.01% (30 g); 0.025% (30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Retin-A Micro Pump: 0.04% (20 g, 45 g); 0.1% (50 g) [contains benzyl alcohol, disodium edta, propylene glycol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vitamin A Acid: 0.01% (25 g); 0.025% (25 g), 0.05% (25 g) [contains isopropyl alcohol, tetrasodium edta, propylene glycol, trolamine (triethanolamine), methylparaben, propylparaben]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230474\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Prior to application, wash hands; gently wash face with a mild soap; pat dry and wait 20 to 30 minutes. Apply thin layer to affected area in the evening or before bedtime, avoiding eyes, ears, nostrils, and mouth. If stinging or irritation develop, temporarily discontinue or decrease frequency of application. Wash hands immediately after applying. Avoid use of products to the affected area that contain high concentrations of alcohol, astringents, or spices. Do not apply to sunburned skin. If combination topical therapy is required, consider separating applications (eg, one drug in the morning and the other in the evening or before bedtime).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Retin-A Micro: Avoid contact with lime peel and application area.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49132672\" class=\"block hazard drugH1Div\"><span class=\"drugH1\">Hazardous Drugs Handling Considerations</span>\n    <p style=\"text-indent:0em;\">Hazardous agent (NIOSH 2016 [group 3]).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Use appropriate precautions for receiving, handling, administration, and disposal (NIOSH 2016). Gloves (single) should be worn during receiving, unpacking, and placing in storage.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">NIOSH recommends double gloving, a protective gown, and (if liquid that could splash) eye/face protection for administration of a topical product; if there is potential for inhalation, respiratory protection is recommended (NIOSH 2016). Assess risk to determine appropriate containment strategy (USP-NF 2017).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230473\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acne vulgaris:</b> Atralin, Avita, Retin-A, Retin-A Micro, Stieva-A [Canadian product], Tretin-X, Vitamin-A Acid [Canadian product]: Treatment of acne vulgaris.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Palliation of fine wrinkles:</b> Renova: Adjunctive treatment for mitigation (palliation) of fine wrinkles in patients who use comprehensive skin care and sun avoidance programs.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Palliation of fine wrinkles, mottled hyperpigmentation, and facial skin roughness:</b> Refissa: Adjunctive treatment for mitigation (palliation) of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin in patients who do not achieve such palliation using comprehensive skin care and sun avoidance programs alone.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230514\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Tretinoin may be confused with ISOtretinoin, Tenormin, triamcinolone, trientine</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Renova [U.S., Canada] may be confused with Remov brand name for nimesulide [Italy]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230465\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">1% to 10%: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dermatologic: Burning sensation of the skin (gel: 8%), skin irritation (gel: 4% to 6%; severe: 1% to &le;3%), erythema (5%), dermatitis (gel: 4%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Local: Skin edema</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&lt;1%, postmarketing, case reports, and frequency not defined: Acne flare (initial), contact dermatitis (rare), crusted skin, exfoliation of skin, hyperpigmentation or hypopigmentation (temporary), pharyngitis, pruritus, skin blister, skin pain, skin photosensitivity, xeroderma</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230477\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to tretinoin or any component of the formulation. <b>Note:</b> There are no contraindications listed in Atralin or Retin-A Micro US labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Documentation of allergenic cross-reactivity for retinoids is limited. However, because of similarities in chemical structure and/or pharmacologic actions, the possibility of cross-sensitivity cannot be ruled out with certainty.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230462\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Fish allergies: Atralin gel contains soluble fish proteins; use caution in patients with sensitivities or allergies to fish.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity reactions: Discontinue tretinoin if drug sensitivity, chemical irritation, or a systemic adverse reaction occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Photosensitivity: Use is associated with increased susceptibility/sensitivity to UV light; avoid or minimize excessive exposure to sunlamps or sunlight. Daily sunscreen (SPF 15 or higher) use and other protective measures (eg, clothing over treated areas) are recommended. Use with caution in patients with personal or family history of skin cancer.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Skin irritation: Treatment can increase skin sensitivity to weather extremes of wind or cold. Excessive dryness, redness, and swollen or blistered skin may occur. Also, concomitant topical medications (eg, medicated or abrasive soaps, cleansers, or cosmetics with a strong drying effect) should be used with caution due to increased skin irritation. Reduce the amount, frequency, or discontinue use until irritation disappears.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Eczema: Use with caution in patients with eczema; may cause severe irritation.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cream 0.02%: Do not use the 0.02% cream for longer than 52 weeks when using for palliation of fine wrinkles.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cream 0.05%: Do not use the 0.05% cream for longer than 48 weeks when using for palliation of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Gel: Flammable; do not expose to high temperatures or flame.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For external use only; avoid contact with abraded skin, sunburned skin, mucous membranes, eyes, mouth, angles of the nose. When used for palliation of fine wrinkles, mottled hyperpigmentation, or facial skin roughness, should be used as part of a comprehensive skin care and sun avoidance program.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230502\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230467\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=10014&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aminolevulinic Acid (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Systemic). <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Aminolevulinic Acid (Topical): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Topical). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Fluoride (with ADE): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Minerals (with AE, No Iron): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Verteporfin: Photosensitizing Agents may enhance the photosensitizing effect of Verteporfin. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230486\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">Vitamin A toxicity may rarely occur. Management: Avoid excessive intake of vitamin A (cod liver oil, halibut fish oil). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230469\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230480\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events were observed in animal reproduction studies following topical application of tretinoin. Teratogenic effects were also observed in pregnant women following topical use; however, a causal association has not been established. When treatment for acne is needed during pregnancy, other agents are preferred (Kong, 2013). These products should not be used for palliation of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin in women who are pregnant, attempting to conceive, or at high risk for pregnancy.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F17918149\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if tretinoin (topical) is excreted into breast milk. The manufacturer recommends that caution be exercised when administering tretinoin (topical) to nursing women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230461\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Tretinoin is a derivative of vitamin A. When used topically, it modifies epithelial growth and differentiation.  In patients with acne, it decreases the cohesiveness of follicular epithelial cells and decreases micromedo formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells causing extrusion of the comedones.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230476\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: Acne: &ge;2 weeks, may take &ge;7 weeks; Facial wrinkles: Up to 6 months</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Minimal</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Bioavailability: Avita cream and gel: &lt;0.3%; Retin A Micro 0.1% gel: ~1%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic; forms metabolites</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine and feces</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230479\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Avita External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (20 g): $107.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Refissa External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.05% (20 g): $106.91</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Renova External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.02% (40 g): $316.45</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Renova Pump External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.02% (44 g): $334.25</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Retin-A External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (20 g): $158.21</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.05% (20 g): $177.44</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (20 g): $207.10</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Tretin-X External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.075% (35 g): $311.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Tretinoin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (20 g): $100.44</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.05% (20 g): $112.64</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (20 g): $131.47</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Atralin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.05% (45 g): $674.89</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Avita External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (20 g): $107.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Retin-A External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.01% (15 g): $125.65</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (15 g): $126.76</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Retin-A Micro External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.04% (20 g): $523.03</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (20 g): $523.03</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Retin-A Micro Pump External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.04% (50 g): $1,098.18</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.06% (50 g): $1,093.60</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.08% (50 g): $1,093.60</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (50 g): $1,098.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Tretinoin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.01% (15 g): $79.76</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.025% (15 g): $80.47</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.05% (45 g): $337.43</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Tretinoin Microsphere External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.04% (20 g): $300.04</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (20 g): $300.04</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F230481\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A-Acido (AR);</li>\n      <li>Aberela (SE);</li>\n      <li>Acetretin (AE);</li>\n      <li>Acfen-A (MX);</li>\n      <li>Acid A Vit (NL);</li>\n      <li>Acnatac (DE);</li>\n      <li>Acnederm (BG);</li>\n      <li>Airol (AE, BH, CH, DE, GR, IT, KW, MY, PH, PK, PL, QA, TW);</li>\n      <li>Alten (MY);</li>\n      <li>Avitcid (FI);</li>\n      <li>Betarretin (PE);</li>\n      <li>Cordes VAS (DE);</li>\n      <li>Cosmotrin (BD);</li>\n      <li>Curacne (KW);</li>\n      <li>Derm A (PH);</li>\n      <li>Effederm (FR);</li>\n      <li>Eudyna (MY);</li>\n      <li>Idaman (ID);</li>\n      <li>Ketrel (HK);</li>\n      <li>Li Ling (CN);</li>\n      <li>Locacid (IL, PT, SK);</li>\n      <li>Melavita (ID);</li>\n      <li>Neocare (ES);</li>\n      <li>Nilac (BD);</li>\n      <li>Optimal Gel (ET);</li>\n      <li>Renova (ZA);</li>\n      <li>Retacnyl (CR, DO, GT, HN, KR, MX, MY, NI, PA, PE, PH, SG, SV, VE);</li>\n      <li>Retavit (IL);</li>\n      <li>Reticrem (CO);</li>\n      <li>Retigel (CO, CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Retin A (AT, GR, IT, PT);</li>\n      <li>Retin-A (AE, BB, BH, BR, CH, CO, FR, ID, JO, KW, LB, MT, MX, PE, PH, PK, QA, SA, TH, UY, ZA, ZW);</li>\n      <li>Retino-A (IN);</li>\n      <li>Retinova (SE);</li>\n      <li>Retirides (ES);</li>\n      <li>Retrieve (NZ, SG);</li>\n      <li>Retrieve Cream (AU);</li>\n      <li>Reviderm (ID);</li>\n      <li>Roaccutane (BH, KW, QA, SA);</li>\n      <li>Stieva-A (AU, CL, CO, KR, MX, MY, PY, SG, TH, UY);</li>\n      <li>Stieva-A Forte (MY);</li>\n      <li>T3 Actin (ET, MY, VN);</li>\n      <li>T3Actin (PH);</li>\n      <li>Tracne (HK);</li>\n      <li>Tracnesan (LK);</li>\n      <li>Trena (BD);</li>\n      <li>Trentin (ID);</li>\n      <li>Tretin-A (LK);</li>\n      <li>Trinon (BD)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    &lt;800&gt; Hazardous Drugs&mdash;Handling in Healthcare Settings. <i>United States Pharmacopeia and National Formulary</i> (USP 40-NF 35). Rockville, MD: United States Pharmacopeia Convention; 2017:83-102.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Atralin gel (tretinoin) [prescribing information]. Bridgewater, NJ: Coria Laboratories; August 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Avita cream (tretinoin) [prescribing information]. Morgantown, WV: Mylan Pharmaceuticals; November 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Eichenfield LF, Krakowski AC, Piggott C, et al. American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. <i>Pediatrics</i>. 2013;131 Suppl 3:S163-86. doi: 10.1542/peds.2013-0490B.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/topical-tretinoin-topical-all-trans-retinoic-acid-drug-information/abstract-text/23637225/pubmed\" target=\"_blank\" id=\"23637225\">23637225</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. <i>Drugs</i>. 2013;73(8):779-87. doi: 10.1007/s40265-013-0060-0.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/topical-tretinoin-topical-all-trans-retinoic-acid-drug-information/abstract-text/23657872/pubmed\" target=\"_blank\" id=\"23657872\">23657872</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    National Institute for Occupational Safety and Health (NIOSH), &quot;NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.&quot; Available at <a href=\"http://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">http://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf</a>. Accessed January 21, 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Renova cream (tretinoin) [prescribing information]. Bridgewater, NJ: Valeant; January 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Retin-A (tretinoin) [product monograph]. Montreal, Quebec, Canada: Valeant Canada LP; March 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Retin-A Micro (tretinoin) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; January 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Retin-A Micro (tretinoin) [product monograph]. Laval, Quebec, Canada: Valeant Canada LP; March 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Stieva-A (tretinoin) [product monograph]. Mississauga, Ontario, Canada: GlaxoSmithKline Inc; August 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tretin-X (tretinoin) [prescribing information]. Cumberland, RI: Onset Dermatologics; February 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    US Department of Health and Human Services; Centers for Disease Control and Prevention; National Institute for Occupational Safety and Health. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2016. <a href=\"http://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf\" target=\"_blank\">http://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf</a>. Updated September 2016. Accessed October 5, 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vitamin A Acid (tretinoin) [product monograph]. Montreal, Quebec, Canada: Valeant Canada LP/Valeant Canada S.E.C.; February 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Winston MH, Shalita AR, &ldquo;Acne Vulgaris, Pathogenesis and Treatment,&rdquo; <i>Pediatr Clin North Am</i>, 1991, 38(4):889-903.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/topical-tretinoin-topical-all-trans-retinoic-acid-drug-information/abstract-text/1831256/pubmed\" target=\"_blank\" id=\"1831256\">1831256</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 10014 Version 203.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F230490\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F230491\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F230507\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F230493\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F230501\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F230494\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F24037518\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F24037519\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F230472\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F230458\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms: Canada\" href=\"#F45759681\" class=\"outlineLink\">Dosage Forms: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F230474\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Hazardous Drugs Handling Considerations\" href=\"#F49132672\" class=\"outlineLink\">Hazardous Drugs Handling Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F230473\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F230514\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F230465\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F230477\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F230462\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F230502\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F230467\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F230486\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F230469\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F230480\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F17918149\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F230461\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F230476\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F230479\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F230481\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/10014|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=topical-tretinoin-topical-all-trans-retinoic-acid-patient-drug-information\" class=\"drug drug_patient\">Topical tretinoin (topical all-trans retinoic acid): Patient drug information</a></li><li><a href=\"topic.htm?path=topical-tretinoin-topical-all-trans-retinoic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">Topical tretinoin (topical all-trans retinoic acid): Pediatric drug information</a></li></ul></div></div>","javascript":null}